Deep Track Capital as of June 30, 2022
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 51 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Global Blood Therapeutics In | 7.7 | $117M | 3.6M | 31.95 | |
| Novocure Ord Shs (NVCR) | 6.1 | $93M | 1.3M | 69.50 | |
| Travere Therapeutics (TVTX) | 5.7 | $87M | 3.6M | 24.23 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.1 | $78M | 500k | 156.01 | |
| Alnylam Pharmaceuticals Call Option (ALNY) | 4.8 | $73M | 500k | 145.85 | |
| Kura Oncology (KURA) | 4.5 | $68M | 3.7M | 18.33 | |
| Madrigal Pharmaceuticals (MDGL) | 4.3 | $65M | 905k | 71.58 | |
| Chinook Therapeutics | 3.9 | $60M | 3.4M | 17.49 | |
| BioMarin Pharmaceutical (BMRN) | 3.6 | $54M | 654k | 82.87 | |
| Fate Therapeutics (FATE) | 3.3 | $50M | 2.0M | 24.78 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.2 | $49M | 2.9M | 16.78 | |
| Beam Therapeutics (BEAM) | 3.2 | $48M | 1.3M | 38.71 | |
| Iveric Bio | 2.8 | $43M | 4.5M | 9.62 | |
| Agenus Com New | 2.8 | $43M | 22M | 1.94 | |
| Esperion Therapeutics (ESPR) | 2.5 | $38M | 6.0M | 6.36 | |
| Repare Therapeutics Ord (RPTX) | 2.5 | $38M | 2.7M | 13.99 | |
| Nuvation Bio Com Cl A (NUVB) | 2.4 | $37M | 12M | 3.24 | |
| Immunovant (IMVT) | 2.4 | $37M | 9.5M | 3.90 | |
| Nkarta (NKTX) | 2.3 | $35M | 2.8M | 12.32 | |
| Nurix Therapeutics (NRIX) | 2.0 | $31M | 2.4M | 12.67 | |
| Forma Therapeutics Hldgs SHS | 1.8 | $28M | 4.1M | 6.89 | |
| Tricida | 1.7 | $26M | 2.7M | 9.68 | |
| ACADIA Pharmaceuticals (ACAD) | 1.6 | $24M | 1.7M | 14.09 | |
| Dyne Therapeutics (DYN) | 1.6 | $24M | 3.5M | 6.87 | |
| 4d Molecular Therapeutics In (FDMT) | 1.4 | $22M | 3.1M | 6.98 | |
| Keros Therapeutics (KROS) | 1.3 | $20M | 740k | 27.63 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.3 | $20M | 1.1M | 18.65 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $18M | 1.8M | 9.84 | |
| Dice Therapeutics | 1.1 | $16M | 1.0M | 15.52 | |
| Inozyme Pharma (INZY) | 1.0 | $16M | 3.3M | 4.77 | |
| Schrodinger (SDGR) | 1.0 | $15M | 562k | 26.41 | |
| Acumen Pharmaceuticals (ABOS) | 1.0 | $15M | 3.1M | 4.70 | |
| Anaptysbio Inc Common (ANAB) | 0.9 | $14M | 673k | 20.30 | |
| Miragen Therapeutics (VRDN) | 0.9 | $14M | 1.2M | 11.57 | |
| Adicet Bio (ACET) | 0.9 | $13M | 892k | 14.60 | |
| Jounce Therapeutics | 0.8 | $13M | 4.3M | 3.03 | |
| Silence Therapeutics Ads (SLN) | 0.7 | $11M | 952k | 11.85 | |
| Relmada Therapeutics (RLMD) | 0.6 | $9.5M | 500k | 18.99 | |
| Hookipa Pharma Inc equity | 0.5 | $8.2M | 5.0M | 1.63 | |
| Century Therapeutics (IPSC) | 0.5 | $7.8M | 925k | 8.40 | |
| Magenta Therapeutics | 0.4 | $6.4M | 5.4M | 1.20 | |
| Assembly Biosciences | 0.4 | $6.3M | 3.0M | 2.10 | |
| Sage Therapeutics (SAGE) | 0.4 | $5.5M | 172k | 32.30 | |
| Passage Bio (PASG) | 0.4 | $5.5M | 2.3M | 2.36 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $5.0M | 499k | 9.98 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $4.9M | 1.0M | 4.90 | |
| Gritstone Oncology Ord (GRTS) | 0.3 | $4.2M | 1.7M | 2.42 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $2.7M | 484k | 5.63 | |
| Protagonist Therapeutics Put Option (PTGX) | 0.1 | $2.1M | 261k | 7.91 | |
| Atyr Pharma Com New (ATYR) | 0.1 | $823k | 291k | 2.83 | |
| Vigil Neuroscience (VIGL) | 0.1 | $796k | 308k | 2.58 |
